Document is current
Any future updates will be listed below
-
Authors
Bley, Maximilian
Mathez, Linda
Menz, Susanne
Stephan, Isabella
Regitz-Zagrosek, Vera
Lerchenmueller, Marc J.
Lerchenmüller, Carolin https://orcid.org/0000-0002-5620-0285
-
Funding
Funding for this research was provided by:
University of Zurich
- License Information
-
More Information
Article History
Received: 15 August 2025
Accepted: 28 October 2025
First Online: 26 November 2025
Declarations
:
: ML is a co-founder and shareholder of AaviGen GmbH, a cardiovascular gene therapy company while the present study is not related to the company. The remaining authors have no competing interest to declare.
